| Acute treatment of hypertensive intracerebral hemorrhage. | |
| | |
MedLine Citation:
|
PMID: 20848325 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OPINION STATEMENT: Hypertensive intracerebral hemorrhage remains an entity in search of definitive treatment. It requires management in a specialized unit, where hypertension, hyperglycemia, seizures, and elevated intracranial pressure can be expertly managed. However, the exact target range of hypertensive therapy is uncertain. Extraventricular drainage and surgery for cerebellar hemorrhage can both be life-saving. The role of craniotomy for hematoma resection remains unclear. Surgery for deep or pontine hemorrhages has questionable value. The reduction of clot expansion acutely may lead to improved outcomes. One option to this end, the tight control of hypertension acutely, may be difficult to prove effective. Another, the use of factor VIIa, eluded validation in one trial. Efforts are under way to reduce intraventricular hemorrhage, and with it, hydrocephalus. The role of clot evacuation in the subset of individuals with lobar hemorrhage is also being studied. In all likelihood, the key to acute treatment of this condition will be early intervention, with implementation of blood pressure control, administration of clotting factors in the emergency department, or both. This treatment will be followed by transfer to a specialized unit, with appropriate interventions in selected patients. However, morbidity and mortality will remain high, pointing out the importance of prevention through management of hypertension. |
| | |
Authors:
|
Thomas Mirsen |
Related Documents
:
|
11059635 - Preserving target-organ function with candesartan cilexetil in patients with hypertension. 9481615 - Should a modern antihypertensive drug possess cardioprotective properties? 17534465 - More medications, fewer pills: combination medications for the treatment of hypertension. 11695075 - Management options for hypertension syndrome. 1199705 - The frequency of fetal bradycardia during selective epidural anaesthesia. 11059635 - Preserving target-organ function with candesartan cilexetil in patients with hypertension. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current treatment options in neurology Volume: 12 ISSN: 1534-3138 ISO Abbreviation: Curr Treat Options Neurol Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815940 Medline TA: Curr Treat Options Neurol Country: United States |
Other Details:
|
Languages: eng Pagination: 504-17 Citation Subset: - |
Affiliation:
|
Division of Neurology, Cooper University Hospital-UMDNJ, 3 Cooper Plaza, Suite 320, Camden, NJ, 08103, USA, mirsen-tom@cooperhealth.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Management of patent foramen ovale and stroke.
Next Document: Treatment of tics and tourette syndrome.